CAMBRIDGE NUTRACEUTICALS LIMITED

Active Cambridge

Other human health activities

30 employees website.com
Healthcare and wellbeing Other human health activities
C

CAMBRIDGE NUTRACEUTICALS LIMITED

Other human health activities

Founded 22 Jul 2010 Active Cambridge, England 30 employees website.com
Healthcare and wellbeing Other human health activities

Previous Company Names

CAMNUTRA LIMITED 10 Feb 2012 — 21 Aug 2015
BIOSCIENCE HEALTHCARE LIMITED 22 Jul 2010 — 10 Feb 2012
Accounts Submitted 29 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 12 Sept 2025 Next due 9 Sept 2026 4 months remaining
Net assets £2M £369K 2024 year on year
Total assets £4M £275K 2024 year on year
Total Liabilities £2M £94K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Suite 4 23 King Street Cambridge CB1 1AH England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CAMBRIDGE NUTRACEUTICALS LIMITED (07322398), an active healthcare and wellbeing company based in Cambridge, England. Incorporated 22 Jul 2010. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£254.86k

Decreased by £279.25k (-52%)

Net Assets

£1.81M

Increased by £369.32k (+26%)

Total Liabilities

£1.74M

Decreased by £94.42k (-5%)

Turnover

N/A

Employees

30

Increased by 5 (+20%)

Debt Ratio

49%

Decreased by 7 (-13%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Apr 2016Crowdfunding
Investor 2Apr 2016Crowdfunding

Share Capital

Share Capital

Share allotments and capital structure

33 Allotments 10,573,152 Shares £116.92m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Jul 2025100,000£124k£1.24
24 Sept 2024100,000£124k£1.24
27 Jun 2024100,000£100.00m£1k
18 May 20222,000£920£0.46
12 Nov 2020222,222£0£0

Officers

Officers

3 active
Status
Jeffrey Michael IliffeDirectorBritishUnited Kingdom649 Dec 2016Active
Michelle CorpDirectorBritishEngland531 Feb 2024Active
Timothy George DyeDirectorBritishEngland632 Jan 2013Active

Shareholders

Shareholders (145)

Syndicate Room Nominees Ltd
11.4%
1,317,212
David D. Cleevely
9.8%
1,130,904

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Adam Robert David Cleevely

Ceased 1 Jul 2016

Ceased

Timothy George Dye

Ceased 1 Jul 2016

Ceased

Group Structure

Group Structure

CAMBRIDGE NUTRACEUTICALS LIMITED Current Company
PRIME FIFTY LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
12 Sept 2025OfficersTermination of Matthew Keys as director on 10 Sept 2025
12 Sept 2025Confirmation StatementConfirmation statement made on 26 Aug 2025 with updates
29 Jul 2025OfficersChange to director Mr Matthew Keys on 28 Jul 2025
28 Jul 2025CapitalAllotment of shares (GBP 2,119,212.36) on 28 Jul 2025
29 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

12 Sept 2025 Officers

Termination of Matthew Keys as director on 10 Sept 2025

12 Sept 2025 Confirmation Statement

Confirmation statement made on 26 Aug 2025 with updates

29 Jul 2025 Officers

Change to director Mr Matthew Keys on 28 Jul 2025

28 Jul 2025 Capital

Allotment of shares (GBP 2,119,212.36) on 28 Jul 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

7 months ago on 29 Sept 2025

Termination of Matthew Keys as director on 10 Sept 2025

7 months ago on 12 Sept 2025

Confirmation statement made on 26 Aug 2025 with updates

7 months ago on 12 Sept 2025

Change to director Mr Matthew Keys on 28 Jul 2025

9 months ago on 29 Jul 2025

Allotment of shares (GBP 2,119,212.36) on 28 Jul 2025

9 months ago on 28 Jul 2025